WELL

Welltower
D

WELL

Arincen66/100B

If you had invested in Welltower ago, it would be worth $5,362 today, against $4,305 in SPY and $6,524 in QQQ.

ArincenArincen ScoreBeta

66/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability4

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation7.5

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength4

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

Welltower key facts

Style
Growth stock · 10.0/10Growth 10.0 · Value 2.1 · Dividend 3.7
Day range
241.010 – 248.510
52-week range
180.970 – 255.200
Market capitalization
181.90B USD
P/E
119.78
EPS
2.07
Div Yield
1.37%
EPS growth forecast (FY2026)
+100.5%
Volume
124,280
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
Shankh S. Mitra
Employees
712
IPO date
19 Mar 1980

Welltower earnings

Next earnings · Q4 FY2026
EPS estimate
0.69 USD
Revenue estimate
3.84B USD
Last quarter · Q3 FY2026
EPS0.54Missed -15.8%Revenue3.72BBeat +2.0%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q1 FY20270.71——-30.56%3.98B——+18.83%
Q4 FY20260.69——+393.57%3.84B——+20.81%
Q3 FY20260.640.54-15.76%+31.71%3.64B3.72B+2.00%+38.35%
Q2 FY20260.620.61-1.13%+32.61%3.40B3.54B+4.15%+39.10%
Q1 FY20260.681.02+50.22%+155.00%3.18B3.35B+5.54%+38.33%
Q4 FY20250.580.14-75.74%-26.32%2.86B3.18B+11.30%+41.33%
Q3 FY20250.590.41-30.51%-43.84%2.61B2.69B+2.79%+30.65%
Q2 FY20250.460.46+1.05%+9.52%2.47B2.55B+3.34%+39.64%

Welltower analyst forecast

12-month price target
261.17 USD
+5.33%

Analysts' 1-year price targets range from 246.00 to 275.00, with an average of 261.17.

Past year
1-year forecast
Strong sellStrong buy
Buy
15 ratings
Strong buy
0
Buy
14
Hold
1
Sell
0
Strong sell
0

12-month price target

Highest target275.00
Average target261.17
Lowest target246.00
Current price247.95

Welltower valuation

Price to earnings ratio (TTM)
119.78
Forward P/E (FY2026)
87.72
Price to sales (TTM)
13.28
Price to book
3.74
EV / EBITDA (TTM)
59.77

Capital structure

Market capitalization
181.90B USD
+
Total debt
21.16B USD
−
Cash and short-term investments
2.27B USD
=
Enterprise value
200.79B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)61.67————
FY2027 (est.)75.8661.67———
FY2026 (est.)87.7275.86———
Now (TTM)119.7877.4613.283.7459.77
FY2025131.6465.6411.582.9360.55
FY202479.7768.989.682.3832.12
FY2023136.6250.457.181.8325.25
FY2022211.4586.315.251.4921.88
FY2021108.57200.337.742.0729.68

Welltower against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Prologis, Equinix, American Tower, Simon Property Group, Digital Realty Trust, and Public Storage, the US Real Estate companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median119.8
    64.5362.0
  • Gross marginAbove its median39.2%
    38.4%41.1%
    Against its peers: 6 of 7Peers' median 57.5%
  • Operating marginLowest in 5 years3.3%
    3.3%16.2%
    Against its peers: 7 of 7Peers' median 43.0%
  • Net marginAbove its median8.8%
    2.4%12.1%
    Against its peers: 7 of 7Peers' median 30.4%
  • Return on equityAbove its median2.2%
    0.7%3.0%
    Against its peers: 7 of 7Peers' median 14.4%
  • Free cash flow marginAbove its median26.7%
    22.5%28.0%
    Against its peers: 6 of 7Peers' median 44.9%
  • Revenue growthHighest in 5 years35.8%
    2.7%35.8%
    Against its peers: 1 of 7Peers' median 6.3%
  • EPS growthAt its median-11.5%
    -66.5%137.9%
    Against its peers: 5 of 7Peers' median 36.9%
  • Debt to EBITDAHighest in 5 years9.25×
    6.03×9.25×
    Against its peers: 7 of 7Peers' median 5.22×
  • Current ratioHighest in 5 years5.34
    1.935.34
    Against its peers: 1 of 7Peers' median 0.57

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Welltower growth and profitability

Revenue (TTM)
13.70B USD
Net income (TTM)
1.46B USD
Gross margin
38.79%
Operating margin
5.41%
Net margin
10.67%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202510.67B+35.82%936.85M-1.56%39.18%3.33%8.78%2.31B-16.84%
FY20247.85B+21.23%951.68M+179.83%38.50%14.59%12.12%2.78B+15.71%
FY20236.48B+12.16%340.09M+140.84%39.06%14.52%5.25%2.40B+17.73%
FY20225.78B+22.65%141.21M-57.99%38.39%12.92%2.44%2.04B+19.01%
FY20214.71B+2.68%336.14M-65.66%41.09%16.21%7.14%1.71B+11.82%

Welltower revenue breakdown

By product

FY2025
Senior Housing - Operating: 81.1%Triple Net: 11.4%Outpatient Medical: 7.5%81.1%Senior Housing - Operating11.4%Triple Net7.5%Outpatient Medical
SegmentRevenueShare of revenueChange on the year
Senior Housing - Operating8.49B81.1%+40.7%
Triple Net1.20B11.4%+51.8%
Outpatient Medical781.93M7.5%-2.5%

By region

FY2025
UNITED STATES: 73.2%UNITED KINGDOM: 20.0%CANADA: 6.8%73.2%UNITED STATES20.0%UNITED KINGDOM6.8%CANADA
RegionRevenueShare of revenueChange on the year
UNITED STATES7.94B73.2%+20.9%
UNITED KINGDOM2.17B20.0%+148.4%
CANADA734.34M6.8%+32.4%

How Welltower makes its money

Revenue10.67B 100.0%
Cost of revenue6.49B 60.8%
Gross profit4.18B 39.2%
Selling and administration1.75B 16.4%
Other operating expenses2.08B 19.5%
Operating income355.17M 3.3%
Net income936.85M 8.8%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Welltower dividends

Annual dividend
3.40 USD
Dividend yield (indicated)
1.37%
Payout ratio (FFO)
48.94%
Years of dividend growth
3
Frequency
Quarterly
Last payment
0.85 USD
Last ex-dividend date
10 Nov 2026
Last payment date
19 Nov 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share2.822.562.442.442.442.703.483.483.483.44

Welltower financial health

Cash and short-term investments
2.27B USD
Total debt
21.16B USD
Net cash
-18.89B USD
Free cash flow (TTM)
2.26B USD
Current ratio
2.03
Debt to equity
0.44
Piotroski score
5 / 9
Altman Z-score
4.50

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20255.03B21.38B2.85B
FY20243.51B16.76B2.20B
FY20231.99B16.12B1.55B
FY2022631.68M14.96B1.30B
FY2021269.27M14.68B1.26B

Welltower ownership

Institutions
101.88%
Institutional holders
1,647 (+104)
Free float
99.86%
InstitutionsOthers
As of 30 Jun 2026

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 20264010.07K2.15K
Q2 2026002.72K6.64K
Q1 2026002.16M665.00
Q4 2025008.17M553.00

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025665.64M679.52M+11.63%
FY2024602.98M608.75M+17.36%
FY2023515.63M518.70M+11.51%
FY2022462.19M465.16M+8.98%
FY2021424.98M426.84M+2.27%

Source: Financial Modeling Prep

Related Instruments

Title: Welltower

Sector: Real Estate
Industry: REIT - Healthcare Facilities
Welltower owns a diversified healthcare portfolio of 2,950 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.

Common questions about Welltower stock

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.